Kevin Dietsch/Getty Images News
EMD Serono, the U.S. healthcare business of Germany’s Merck KGaA (OTCPK:MKGAF), has brokered an agreement with the Trump administration to provide its in vitro fertilization at a deep discount to US consumers through the TrumpRx prescription drug program.
The company